Pressure BioSciences, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Richard T. Schumacher
- Full Time Employees
- 15
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 14 Norfolk Avenue Canton MA United States of America 02375
- IPO Date
- Oct 31, 1996
- CIK
- 0000830656
- Website
- pressurebiosciences.com
- Similar Companies
- Business
- Pressure BioSciences, Inc. specializes in the development and commercialization of innovative pressure-based platform technologies for the global life sciences industry. The company offers core products and services based on three patented, pressure-enhanced platforms: Pressure Cycling Technology (PCT); the BaroFold Platform for novel protein therapeutics development; and Ultra Shear Technology (UST) for high-pressure processing applications. Key products include Barocyclers, Barocycler accessories, microtubes, microtube accessories, pressure calibration device kits, and the UltraShear equipment series. These products serve biopharmaceutical drug manufacturers by enabling biomolecular control for applications such as biomarker discovery, drug development and design, forensics, biotherapeutics characterization, vaccine development, soil and plant biology, and counter-bioterrorism. Founded in 1978 and headquartered in Canton, Massachusetts, Pressure BioSciences operates globally, having installed over 300 PCT systems in approximately 200 sites worldwide. The company targets biopharmaceutical companies, research institutions, and diagnostics providers. Recent major developments within the last two years include the acquisition of wellness firm Uncle Bud's Health and Wellness in early 2024, the relocation to a new manufacturing facility consolidating R&D and expanding UltraShear equipment development and contract manufacturing, and an upcoming commercial launch of new nanoemulsified products expected in Q3/Q4 2024 featuring next-generation skincare formulations with nano-retinol, nootropic enhancers, and antioxidant cocktails. Additionally, Pressure BioSciences has begun placements of first-generation UltraShear benchtop equipment into cannabis companies for THC edible product manufacturing. Their next-generation GMP-compliant Barocycler EXTREME instrument targets global biopharmaceutical drug makers for therapeutic drug design, characterization, and quality control. Pressure BioSciences holds several patents in hydrostatic pressure applications and licenses research and manufacturing rights related to their BaroFold Platform. Brands under Pressure BioSciences include Barocycler, PULSE, BioSeq, ProteoSolve, ProteoSolveLRS, Power of PCT, PCT Shredder, HUB440, HUB880, Barozyme, BaroFlex, and Strips. The company remains focused on advancing its pressure-based technologies to address unmet needs in protein therapeutics, infectious disease diagnostics, and novel product formulation, reinforcing its leadership in pressure-enabled life sciences innovation worldwide.
Financial Comparison: NexGel (NASDAQ:NXGL) and Pressure BioSciences (OTCMKTS:PBIO)
Head-To-Head Comparison: Pressure BioSciences (OTCMKTS:PBIO) and Artivion (NYSE:AORT)
Head-To-Head Review: Positron (OTCMKTS:POSC) versus Pressure BioSciences (OTCMKTS:PBIO)
Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO)
Pressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray
Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET
Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET
Pressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”
Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.
Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing
Pressure BioSciences, Inc. (PBIO) Acquisition of Uncle Bud's Conference Call (Transcript)
Uncle Bud's to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness
Pressure BioSciences Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds
Pressure BioSciences Announces Closing of Uncle Bud's Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales
Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order
Pressure BioSciences' New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January
Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud's, Forward Integrating PBIO's UltraShear Platform into Multiple Markets
Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud's, Forward Integrating PBIO's UltraShear Platform into Multiple Markets
Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies
Pressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform